Acute & Chronic Pulmonary & Renal Complications Following NCT04827017

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Not yet recruiting

Tracking post- corona virus infection pulmonary and renal complications

Mortality from pulmonary and renal system is highly noticable with COVID-19 pandemic . We trying to monitor compliction

Recruitment information / eligibility
Status	Not yet recruiting
Enrollment	1000
Est. completion date	July 10, 2021
Est. primary completion date	July 5, 2021
Accepts healthy volunteers
Gender	All
Age group	20 Years to 70 Years
Eligibility	Inclusion Criteria: - All COVID 19 patients admitted to ICU Exclusion Criteria: - Refusal to participate

Other:
• follow up
follow up population

Locations
Country	Name	City	State
n/a

Sponsors *(1)*
Lead Sponsor	Collaborator
Minia University

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	renal function	serum creatinine	12 weeks